The United States Patent and Trademark Office (USPTO) received an application to register the trademark
KYVTHREE on Wednesday, November 2, 2022.
The USPTO has assigned this trademark, KYVTHREE, the serial number 97660238.
As of Thursday, November 30, 2023, this trademark filing's federal status is designated as 602.
The trademark KYVTHREE falls under the Pharmaceutical Products category and is associated with the service description of:
"Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease".
602 - ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Status Date
Thursday, November 30, 2023
Registration Number
0000000
Registration Date
NOT AVAILABLE
Mark Drawing
4000 - STANDARD CHARACTER MARK
Published for Opposition Date
NOT AVAILABLE
Trademark Statements
Goods and Services
Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
Classification Information
International Class
005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
